High Squeeze Risk Profile
Recursion Pharmaceuticals (RXRX) has emerged as the top-ranked ticker on the Tapeboard squeeze monitor, boasting a Squeeze Score of 90.2. With 30.8% of its float currently sold short, the stock is exhibiting classic signs of a crowded trade. The days-to-cover ratio stands at 4.9, indicating that any significant upward price momentum could force a rapid covering cycle, exacerbating volatility.
Market Context
While the borrow fee remains relatively low at 0.5%, the high percentage of float shorted makes this a name to watch for institutional positioning. The stock is currently flagged on the threshold list, suggesting persistent failures-to-deliver that often accompany high-conviction short positions. Investors should monitor for any sudden spikes in borrow costs, which would signal a tightening of lendable supply and a potential catalyst for a squeeze.
Signal data sourced from Tapeboard. This post is an original analysis prepared by The Forensic Ledger from publicly available data. Not investment advice.
Not investment advice. This is original reporting and analysis prepared by The Forensic Ledger from publicly available data. Nothing here is a recommendation to buy, sell, or hold any security. Always consult the original source and a licensed professional. See our full disclaimer and source-citation policy.